<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>496-ALPHA-SYMPATHOMIMETICS-(ORAL-AND-OR-NASAL).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ALPHA-SYMPATHOMIMETICS-(ORAL-AND/OR-NASAL)" code="R01AA" /></DRUG1>
<DRUG2>
<CLASS name="DOPAMINERGIC ALKALOIDS OF ERGOT OF RYE" code="G02CB-001" /></DRUG2>
<DESCRIPTION>Risk of constriction of blood vessels and/or rapid elevation of blood pressure</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>496-ALPHA-SYMPATHOMIMETICS-(ORAL-AND-OR-NASAL).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ALPHA-SYMPATHOMIMETICS-(ORAL-AND/OR-NASAL)" code="R01AA" /></DRUG1>
<DRUG2>
<CLASS name="VASOCONSTRICTOR ALKALOIDS OF ERGOT OF RYE" code="N02CA0-001" /></DRUG2>
<DESCRIPTION>Risk of constriction of blood vessels and/or of rapid elevation of blood pressure</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>496-ALPHA-SYMPATHOMIMETICS-(ORAL-AND-OR-NASAL).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ALPHA-SYMPATHOMIMETICS-(ORAL-AND/OR-NASAL)" code="R01AA" /></DRUG1>
<DRUG2>
<CLASS name="IRREVERSIBLE MONOAMINE OXIDASE INHIBITORS (MAOI)" code="N06AF0" /></DRUG2>
<DESCRIPTION>Hypertensive crises (inhibition of the metabolism of the pressor amines). Because of the length of action of the MAOI, this interaction is still possible two weeks after the MAOI is stopped</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>496-ALPHA-SYMPATHOMIMETICS-(ORAL-AND-OR-NASAL).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ALPHA-SYMPATHOMIMETICS-(ORAL-AND/OR-NASAL)" code="R01AA" /></DRUG1>
<DRUG2>
<CLASS name="INDIRECT SYMPATHOMIMETICS" code="C01CA-R01BA" /></DRUG2>
<DESCRIPTION>Risk of constriction of blood vessels and/or of rapid elevation of blood pressure</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
